Browsing Technical documents and research evidence on COVID-19 by Subject "Ribavirin"
Now showing items 1-3 of 3
-
Assessment of the efficacy and safety of Ribavirin in treatment of coronavirus-related pneumonia (SARS, MERS and COVID-19): A protocol for systematic review and meta-analysis
(2020-09-18)Background: The new coronavirus-related pneumonia is causing a global pandemic without specific antiviral drug. Ribavirin has activity against extensive RNA and DNA viruses. We plan to systematically review the use of ... -
Ribavirin was beneficial for patients with SARS and MERS: uncertain if it is effective for patients with COVID-19
(2020-03-20)Citation: Luo T, Na Y, Tan L, et al. The Possibility of Ribavirin in the Treatment of the Coronavirus Disease 2019: A Systematic Review. China Pharmaceuticals 2020; 29(5): 34-9 Language: Chinese What is this? Like COVID-19, ... -
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
(2020-05-08)Background: Effective antiviral therapy is important for tackling the coronavirus disease 2019 (COVID-19) pandemic. We assessed the efficacy and safety of combined interferon beta-1b, lopinavir–ritonavir, and ribavirin for ...